Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 4, 2004 - Issue 1
Submit an article Journal homepage
76
Views
16
CrossRef citations to date
0
Altmetric
Review

Antibody-based treatment of acute myeloid leukaemia

Deborah A Mulford Memorial Sloan-Kettering Cancer Center, Department of Medicine, 1275 York Avenue, Box 458, New York, NY 10021, USA. [email protected]
&
Joseph G Jurcic Memorial Sloan-Kettering Cancer Center, Department of Medicine, 1275 York Avenue, Box 458, New York, NY 10021, USA. [email protected]
Pages 95-105 | Published online: 03 Mar 2005

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

L. Herrera, C. Stanciu-Herrera, C. Morgan, V. Ghetie & E. S. Vitetta. (2006) Anti-CD19 immunotoxin enhances the activity of chemotherapy in severe combined immunodeficient mice with human pre-B acute lymphoblastic leukemia. Leukemia & Lymphoma 47:11, pages 2380-2387.
Read now

Articles from other publishers (15)

Mingxuan Li, Shuping Luo, Yunfang Zhang, Lina Jia, Chuanyu Yang, Xiaoxiang Peng & Ronglan Zhao. (2020) Production, characterization, and application of a monoclonal antibody specific for the extracellular domain of human P2X7R. Applied Microbiology and Biotechnology 104:5, pages 2017-2028.
Crossref
Yan Fang, Yu-Ting Wang, Meng Zhao, Yan-Li Lu, Ming-Xue Li & Ya-Hong Zhang. (2018) Bismuth(III) and diorganotin(IV) complexes of bis(2-acetylpyridine) thiocarbonohydrazone: Synthesis, characterization, and apoptosis mechanism of action in vitro. Polyhedron 155, pages 254-260.
Crossref
Cathy S. Cutler, Heather M. Hennkens, Nebiat Sisay, Sandrine Huclier-Markai & Silvia S. Jurisson. (2012) Radiometals for Combined Imaging and Therapy. Chemical Reviews 113:2, pages 858-883.
Crossref
Johnnie J. Orozco, Jill Zeller & John M. Pagel. (2011) Radiolabeled antibodies directed at CD45 for conditioning prior to allogeneic transplantation in acute myeloid leukemia and myelodysplastic syndrome. Therapeutic Advances in Hematology 3:1, pages 5-16.
Crossref
Nan Yang & Hongzhe Sun. 2010. Biological Chemistry of Arsenic, Antimony and Bismuth. Biological Chemistry of Arsenic, Antimony and Bismuth 53 81 .
Evelien L.J.M. Smits, Zwi N. Berneman & Viggo F.I. Van Tendeloo. (2009) Immunotherapy of Acute Myeloid Leukemia: Current Approaches. The Oncologist 14:3, pages 240-252.
Crossref
Gheath Alatrash & Jeffrey J. Molldrem. 2010. Acute Myelogenous Leukemia. Acute Myelogenous Leukemia 237 255 .
Freddy E EscorciaMichael R McDevittCarlos H VillaDavid A Scheinberg. (2007) Targeted nanomaterials for radiotherapy. Nanomedicine 2:6, pages 805-815.
Crossref
Barbara-Ann Guinn, Azim Mohamedali, N. Shaun B. Thomas & Ken I. Mills. (2006) Immunotherapy of myeloid leukaemia. Cancer Immunology, Immunotherapy 56:7, pages 943-957.
Crossref
Sudhir Tauro, Charles Craddock, Karl Peggs, Gulnaz Begum, Premini Mahendra, Gordon Cook, Judith Marsh, Donald Milligan, Anthony Goldstone, Ann Hunter, Asim Khwaja, Raj Chopra, Timothy Littlewood, Andrew Peniket, Anne Parker, Graham Jackson, Geoff Hale, Mark Cook, Nigel Russell & Stephen Mackinnon. (2005) Allogeneic Stem-Cell Transplantation Using a Reduced-Intensity Conditioning Regimen Has the Capacity to Produce Durable Remissions and Long-Term Disease-Free Survival in Patients With High-Risk Acute Myeloid Leukemia and Myelodysplasia. Journal of Clinical Oncology 23:36, pages 9387-9393.
Crossref
J Kotzerke, D Bunjes & D A Scheinberg. (2005) Radioimmunoconjugates in acute leukemia treatment: the future is radiant. Bone Marrow Transplantation 36:12, pages 1021-1026.
Crossref
Eric J. FeldmanJoseph BrandweinRichard StoneMatt KalaycioJoseph MooreJulie O'ConnorNancy WedelGail J. RobozCarole MillerRaj ChopraJoseph C. JurcicRandy BrownW. Christopher EhmannPhilip SchulmanStanley R. FrankelDaniel De AngeloDavid Scheinberg. (2005) Phase III Randomized Multicenter Study of a Humanized Anti-CD33 Monoclonal Antibody, Lintuzumab, in Combination With Chemotherapy, Versus Chemotherapy Alone in Patients With Refractory or First-Relapsed Acute Myeloid Leukemia. Journal of Clinical Oncology 23:18, pages 4110-4116.
Crossref
Jaspreet Singh Jaggi, Barry J. Kappel, Michael R. McDevitt, George Sgouros, Carlos D. Flombaum, Catalina Cabassa & David A. Scheinberg. (2005) Efforts to Control the Errant Products of a Targeted In vivo Generator . Cancer Research 65:11, pages 4888-4895.
Crossref
Lian-Sheng Li, Christoph Rader, Masayuki Matsushita, Sanjib Das, Carlos F. Barbas, Richard A. Lerner & Subhash C. Sinha. (2004) Chemical Adaptor Immunotherapy:  Design, Synthesis, and Evaluation of Novel Integrin-Targeting Devices. Journal of Medicinal Chemistry 47:23, pages 5630-5640.
Crossref
Diane E. Milenic, Erik D. Brady & Martin W. Brechbiel. (2004) Antibody-targeted radiation cancer therapy. Nature Reviews Drug Discovery 3:6, pages 488-499.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.